Link to this page
Medical Subject Headings
| Preferred Name | Ibandronic Acid | |
| Synonyms |
Bondronat Ibandronic Acid, Sodium Salt, Monohydrate BM210955 RPR 102289A Ibandronate Sodium Anhydrous Phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis- BM 210955 BM21.0955 1-Hydroxy-3-(methylpentylamino)propylidenebisphosphonate Bonviva (1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonate BM-210955 Ibandronate Sodium BM-21.0955 Ibandronate Boniva BM 21.0955 RPR-102289A RPR102289A |
|
| Definitions |
Aminobisphosphonate that is a potent inhibitor of BONE RESORPTION. It is used in the treatment of HYPERCALCEMIA associated with malignancy, for the prevention of fracture and bone complications in patients with breast cancer and bone metastases, and for the treatment and prevention of POSTMENOPAUSAL OSTEOPOROSIS. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000077557 |
|
| altLabel |
Bondronat Ibandronic Acid, Sodium Salt, Monohydrate BM210955 RPR 102289A Ibandronate Sodium Anhydrous Phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis- BM 210955 BM21.0955 1-Hydroxy-3-(methylpentylamino)propylidenebisphosphonate Bonviva (1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonate BM-210955 Ibandronate Sodium BM-21.0955 Ibandronate Boniva BM 21.0955 RPR-102289A RPR102289A
|
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
| cui |
C0287529 C4704778 C0918018 C0379200 C0772244 C1541222 C0918020 C0918019 C0379199
|
|
| DC |
1
|
|
| definition |
Aminobisphosphonate that is a potent inhibitor of BONE RESORPTION. It is used in the treatment of HYPERCALCEMIA associated with malignancy, for the prevention of fracture and bone complications in patients with breast cancer and bone metastases, and for the treatment and prevention of POSTMENOPAUSAL OSTEOPOROSIS.
|
|
| DX |
20190101
|
|
| HN |
2019 (1992)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
23Y0B94E49 UMD7G2653W J12U072QL0 0
|
|
| isa | ||
| LT |
TRD
|
|
| Machine permutation |
2019; IBANDRONIC ACID was indexed under DIPHOSPHONATES 1992-2018
|
|
| MDA |
20180709
|
|
| MMR |
20180703
|
|
| MN |
D02.705.429.500.844
|
|
| notation |
D000077557
|
|
| PA |
D050071
|
|
| prefLabel |
Ibandronic Acid
|
|
| RR |
23Y0B94E49 J12U072QL0 114084-78-5 (Ibandronic Acid)
|
|
| TERMUI |
T678558 T227527 T000940251 T000940252 T403882 T403886 T000940253 T000940254 T403883 T000940250 T227526 T403885 T403884 T227525 T000940249 T000940255
|
|
| TH |
NLM (2004) NLM (1999) FDA SRS (2018) FDA SRS (2017) NLM (1992) USAN (19XX) INN (19XX) NLM (2006) DE
|
|
| tui |
T109 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |